Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,599 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03776812

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Site Reference ID/Investigator #004 Birmingham, Alabama, United States
  • Site Reference ID/Investigator #038 Scottsdale, Arizona, United States
  • Site Reference ID/Investigator #032 Denver, Colorado, United States
  • Site Reference ID/Investigator #001 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

NCT03460483

Conditions
Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +28 more
Locations
  • Summa Akron City Hospital/Cooper Cancer Center Akron, Ohio, United States
  • Aultman Health Foundation Canton, Ohio, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • TriHealth Cancer Institute-Westside Cincinnati, Ohio, United States
View Trial Details
Completed

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

NCT01935934

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View all 19 locations
View Trial Details
Completed

Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

NCT05446870

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • University of Colorado Anschutz Medical Campus-Cancer Clinical Trials Office ( Site 0108) Aurora, Colorado, United States
  • Mayo Clinic in Florida ( Site 0101) Jacksonville, Florida, United States
  • Miami Cancer Institute at Baptist Health, Inc. ( Site 0110) Miami, Florida, United States
  • Northwestern Memorial Hospital ( Site 0104) Chicago, Illinois, United States
View all 45 locations
View Trial Details

Related conditions